Skip to content
Invitris logo

Invitris

Invitris is a YC Winter 2023 (W23) company. Based in Munich, BY, Germany. Team of 6.

  • Biotech
  • Nanotechnology
  • Drug discovery

About Invitris

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Invitris builds a cell-free biomanufacturing platform that converts a digital protein sequence into a physical drug substance in four to eight hours. It targets the gap between AI-designed drugs and the production infrastructure needed to deliver them, replacing slow, batch-oriented cell-based manufacturing with a single-step, autonomous process that works across a wide range of protein classes. A lead application is producing patient-specific bacteriophages to treat antibiotic-resistant infections.

Business model

A fee per manufacturing program run through the platform.

Go-to-market

Invitris sells manufacturing programs to pharmaceutical and biotech developers working on individualized biologics, engaging them directly to run sequences through its platform under GMP-compliant, aseptic conditions.

From the Y Combinator listing

How Invitris describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Creating new protein-based drugs at scale

Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.

Facts

Industry
Healthcare / Healthcare -> Drug Discovery and Delivery
Location
Munich, BY, Germany
Team size
6
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works